NLRP3 and Alzheimer disease: The elimination of the microglial receptor, NLR family pyrin domain containing 3 (NLRP3) has shown to reduce brain Aβ levels in rodent models of AD [26,27]; since then, NLRP3 inflammasome has been deeply studied and characterized in AD [28,29].